United States Assisted Living Facility & Neurorehabilitation Market 2024-2029: Personalized Care Plans, Economic Factors, Aging Population, Increased Awareness Influencing Growth
10. Juli 2024 04:03 ET
|
Research and Markets
Dublin, July 10, 2024 (GLOBE NEWSWIRE) -- The "United States Assisted Living Facility & Neurorehabilitation Market By Region, Competition, Forecast and Opportunities, 2019-2029F" report has been...
Transforming Children's Lives: DP World's Aviv Clinics Dubai’s Revolutionary Youth Protocol
07. Juli 2024 21:00 ET
|
Aviv Clinics
DUBAI, United Arab Emirates, July 07, 2024 (GLOBE NEWSWIRE) -- At DP World's Aviv Clinics Dubai, the world’s most advanced brain and body performance clinic, we understand the heartache parents feel...
Advocating for Traumatic Brain Injury Victims in Alabama: Mike Bell Injury Law Firm Stands Strong
26. April 2024 09:00 ET
|
Mike Bell Accident & Injury Lawyers
BIRMINGHAM, Ala., April 26, 2024 (GLOBE NEWSWIRE) -- Traumatic brain injury (TBI) can be a devastating consequence of accidents caused by negligence, leaving victims and their families grappling...
Biosplice Therapeutics Announces Department of Defense (DoD) Award to Fund Collaboration with The Roskamp Institute to Advance its Neurology Program
08. März 2024 13:36 ET
|
Biosplice Therapeutics, Inc.
Biosplice announced today that its collaboration with The Roskamp Institute has been awarded funding by the US Department of Defense.
Global Neurological Biomarkers Market Analysis Report 2024-2030 - CAGR of 12.8% - Increased Funding For R&D in Biomarkers to Boost Development of New Drugs
24. Januar 2024 05:40 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Neurological Biomarkers Market Size, Share & Trends Analysis Report by Application (Alzheimer's, Parkinson's, Multiple Sclerosis, Autism),...
Moleac’s NeuroAiD™II Improves Post-Concussion Symptoms, Quality of Life, and Mood after a Mild Traumatic Brain Injury
04. Dezember 2023 22:41 ET
|
Moleac Pte Ltd
Promising results from the SAMURAI study show NeuroAiDTMII significantly improves post-concussion symptoms, QoL and mood post-mild traumatic brain injury.
Neurological Biomarkers Research Report 2023: A Global $18.75 Billion Market by 2030 with Pipeline Analysis of Alzheimer's, Parkinson's, Multiple Sclerosis, & Autism Spectrum Disorder
14. November 2023 05:28 ET
|
Research and Markets
Dublin, Nov. 14, 2023 (GLOBE NEWSWIRE) -- The "Neurological Biomarkers Market Size, Share & Trends Analysis Report By Application (Alzheimer's, Parkinson's, Multiple Sclerosis, Autism), By Type,...
Traumatic Brain Injury Market to Register Sustainable Growth by 2032, Evaluates DelveInsight | Leading Companies in the Market - Life Molecular Imaging, Merz, Vasopharm, Pinteon, Omniscient Neurotechnology
18. Oktober 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Traumatic Brain Injury Market to Register Sustainable Growth by 2032, Evaluates DelveInsight | Leading Companies in the Market - Life Molecular...
ZyVersa Therapeutics Announces New Peer-Reviewed Publication Reinforcing the Rationale for Inhibiting ASC Specks with IC 100 to Attenuate Spread of Inflammation into Surrounding Tissues
04. Oktober 2023 07:05 ET
|
ZyVersa Therapeutics
Brain inflammation from traumatic injury releases proinflammatory cytokines that activate inflammasomes in the heart leading to damaging inflammation.
Aviv Clinics Highlights New Literature Review Sharing the Efficacy of Hyperbaric Oxygen Therapy for Traumatic Brain Injury Patients
01. August 2023 13:24 ET
|
Aviv Clinics
ORLANDO, Fla., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Aviv Clinics, one of the most advanced brain clinics in the world, shares the results of a new comprehensive literature review that shows hyperbaric...